Madrid (Reuters) - Last year Madrid’s city and regional governments sold almost 5,000 rent-controlled flats to private equity investors including Goldman Sachs and Blackstone. At the time, the tenants were told their rental conditions would remain the same.
Ericsson’s revenues beat expectations, as the company’s main networks unit saw high mobile broadband demand in places such as China, Russia and the Middle East.
U.S. stock futures pointed lower on Friday, but came off lows seen in Asian hours.
Progress toward closing the gap in incomes between eastern and western Europe has stalled, and in some cases is going in reverse, the International Monetary Fund said.
Germany’s BASF lowered its outlook for 2015 and reported a 4.8% decline in third-quarter profit, hurt by the slowing global economy and weaker demand in Europe.
After reporting a record annual loss this year, Australia’s Qantas Airways turned a profit during its fiscal first quarter, its chief executive said.
A survey finds that a downward trend in German consumer confidence has come to an end, despite cooler growth prospects for Europe's biggest economy.
CHICAGO/LOS ANGELES (Reuters) - A shortage of transportation equipment and possible labor disruptions at the Los Angeles/Long Beach port complex, the nation's busiest, is delaying shipping containers for up to three weeks, threatening timely delivery to retailers for the holiday season.
The whistle-blower who exposed breakthrough cloning research as a devastating fake says South Korea is still dominated by the values that allowed science fraudster Hwang Woo-suk to become an almost untouchable national hero.
WASHINGTON (Reuters) - After months of focus on slack in U.S. labor markets, the Federal Reserve faces a new challenge: the possibility that weak inflation may be so firmly entrenched it upends the return to normal monetary policy.
Spencer, a French-speaking international emergency physician at NewYork-Presbyterian/Columbia, followed all recommendations for any caregiver returning from an Ebola-affected West African country.
SHANGHAI (Reuters) - Australia, Indonesia and South Korea skipped the launch of a China-backed Asian infrastructure bank on Friday as the United States said it had concerns about the new rival to Western-dominated multilateral lenders.
Canada’s chief energy regulator said Thursday a municipality along the route of a crude oil pipeline can’t stop an affiliate of Kinder Morgan Energy from accessing areas for a proposed expansion.
South Korea's second-largest carmaker Kia Motors Corp. says its third-quarter income plunged 27 percent from a year earlier as a stronger won dented profit.
South Korea's economic growth slowed to 3.2 percent in the third quarter, the lowest in five quarters, as weakness in exports and spending by companies offset the boost from government stimulus.
Amazon's trademark smile icon is becoming more of a grimace.
GlaxoSmithKline is considered by many a leading contender for delivering an Ebola vaccine at scale. Recent quotes by the Head of Ebola vaccine research for GSK, however, are sobering and indicate the enormous challenges ahead in the race to deliver a safe and effective vaccine in the quantities needed for the unprecedented outbreak in West Africa. "The thing that is going to have the biggest impact is what is happening to the trajectory of the epidemic curve. If you progress the current trends 2 months into the future are we still in an environment where you can even consider doing a trial?" Dr. Ripley Ballou ‒ Head of Ebola Vaccine Research, GSK (via ScienceInsider here) At the GSK vaccine research facility outside of Brussels, they are working to squeeze 10 years of trial activity into 12 months. The hope is to have 20,000 doses ready to be tested by health workers early next year. "At the same time we have to be able to manufacture the vaccine at doses that would be consistent with general use, and that's going to take well into 2016 to be able to do that. I don't think this can be seen as the primary answer to this particular outbreak. If it does work then to be able to be prepared so that we don't have to go through this again in five years, or whenever the next epidemic is going to break out." Dr. Ripley Ballou ‒ Head of Ebola Vaccine Research, GSK (BBC News Health ‒ here) Earlier today, ScienceInsider published results (here) from leaked documents used in discussions with the World Health Organization (WHO), government officials and vaccine manufacturers.